Bank of Montreal’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bank of Montreal’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3	Closed	-$3K	–	4317
2017 Q4	$3K	Hold	3	–	–	﹤0.01%	4009
2017 Q3	$3K	Hold	3	–	–	﹤0.01%	3974
2017 Q2	$4K	Hold	3	–	–	﹤0.01%	3912
2017 Q1	$4K	Hold	3	–	–	﹤0.01%	3735
2016 Q4	$3K	Hold	3	–	–	﹤0.01%	3838
2016 Q3	$2K	Hold	3	–	–	﹤0.01%	3864
2016 Q2	$2K	Sell	3 -1	-25%	-$861	﹤0.01%	3908
2016 Q1	$4K	Buy	4 +1	+33%	+$929	﹤0.01%	3858
2015 Q4	$3K	Hold	3	–	–	﹤0.01%	3917
2015 Q3	$4K	Hold	3	–	–	﹤0.01%	3690
2015 Q2	$4K	Hold	3	–	–	﹤0.01%	3665
2015 Q1	$2K	Sell	3 -2	-40%	-$1.7K	﹤0.01%	3796
2014 Q4	$6K	Hold	5	–	–	﹤0.01%	3666
2014 Q3	$10K	Hold	5	–	–	﹤0.01%	3659
2014 Q2	$13K	Hold	5	–	–	﹤0.01%	3778
2014 Q1	$16K	Hold	5	–	–	﹤0.01%	3550
2013 Q4	$15K	Hold	5	–	–	﹤0.01%	3308
2013 Q3	$12K	Hold	5	–	–	﹤0.01%	3381
2013 Q2	$11K	Buy	+5	New	+$17.9K	﹤0.01%	3268

Other funds holding SNOA

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Bank of Montreal's SNOA Position: Q1 2018 in Review

Bank of Montreal sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2018, closing a stake of 3 shares — an estimated $3K sold.

Bank of Montreal first reported a position in SNOA in Q2 2013 and held it in 19 quarters. The position peaked at $16K in Q1 2014. 22 funds tracked by Wall St. Rank hold SNOA as of Q1 2018.

Bank of Montreal reported no remaining Sonoma Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Bank of Montreal sold 3 Sonoma Pharmaceuticals shares in Q1 2018, an estimated $3K.
Bank of Montreal first reported a position in Sonoma Pharmaceuticals in Q2 2013 and held it in 19 quarters.
Bank of Montreal's Sonoma Pharmaceuticals position peaked at $16K in Q1 2014.
22 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.